Eastwood Bio-Medical Canada Inc. (EBM.V)
CAD 0.65
(-7.14%)
CAD 0.65
(-7.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -410.58 Thousand CAD | -1717.47% |
| 2022 | -32.32 Thousand CAD | 95.49% |
| 2021 | -495.5 Thousand CAD | 33.74% |
| 2020 | -744.31 Thousand CAD | -41.55% |
| 2019 | -526.01 Thousand CAD | -213.53% |
| 2018 | -540.31 Thousand CAD | 72.09% |
| 2017 | -586.2 Thousand CAD | -17.99% |
| 2016 | -501.46 Thousand CAD | -83.79% |
| 2015 | -258.54 Thousand CAD | 44.33% |
| 2014 | -504.63 Thousand CAD | -241.25% |
| 2013 | -143.62 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -38.11 Thousand CAD | 72.66% |
| 2024 Q2 | -106.62 Thousand CAD | -186.33% |
| 2024 Q3 | -63.91 Thousand CAD | 30.43% |
| 2023 Q3 | -88.1 Thousand CAD | 39.36% |
| 2023 FY | - CAD | -1717.47% |
| 2023 Q1 | -39.09 Thousand CAD | -211.37% |
| 2023 Q2 | -145.29 Thousand CAD | -271.6% |
| 2023 Q4 | -124.98 Thousand CAD | -41.86% |
| 2022 Q3 | 17.21 Thousand CAD | 132.17% |
| 2022 FY | - CAD | 95.49% |
| 2022 Q4 | -12.55 Thousand CAD | -172.95% |
| 2022 Q2 | -53.5 Thousand CAD | -298.6% |
| 2022 Q1 | 26.93 Thousand CAD | -14.56% |
| 2021 FY | - CAD | 33.74% |
| 2021 Q3 | -148.92 Thousand CAD | 25.51% |
| 2021 Q4 | 31.52 Thousand CAD | 121.17% |
| 2021 Q2 | -199.94 Thousand CAD | -18.83% |
| 2021 Q1 | -168.25 Thousand CAD | 15.73% |
| 2020 Q4 | -199.66 Thousand CAD | -688.63% |
| 2020 Q1 | -232 Thousand CAD | -42.03% |
| 2020 Q2 | -275.92 Thousand CAD | -18.93% |
| 2020 Q3 | -25.31 Thousand CAD | 90.82% |
| 2020 FY | - CAD | -41.55% |
| 2019 Q1 | -5148.00 CAD | -101.32% |
| 2019 Q2 | -281.1 Thousand CAD | -5360.51% |
| 2019 Q3 | -69.73 Thousand CAD | 75.19% |
| 2019 Q4 | -163.34 Thousand CAD | -134.23% |
| 2019 FY | - CAD | -213.53% |
| 2018 Q2 | -236.91 Thousand CAD | -35.45% |
| 2018 FY | - CAD | 72.09% |
| 2018 Q4 | 389.95 Thousand CAD | 372.16% |
| 2018 Q3 | -143.28 Thousand CAD | 39.52% |
| 2018 Q1 | -174.9 Thousand CAD | 5.33% |
| 2017 Q1 | -139.55 Thousand CAD | -5.63% |
| 2017 Q2 | -123.7 Thousand CAD | 11.35% |
| 2017 Q4 | -184.75 Thousand CAD | -28.6% |
| 2017 FY | - CAD | -17.99% |
| 2017 Q3 | -143.66 Thousand CAD | -16.13% |
| 2016 Q1 | -94.68 Thousand CAD | -128.85% |
| 2016 Q2 | -124.45 Thousand CAD | -31.45% |
| 2016 Q3 | -150.2 Thousand CAD | -20.69% |
| 2016 FY | - CAD | -83.79% |
| 2016 Q4 | -132.11 Thousand CAD | 12.04% |
| 2015 Q1 | -163.18 Thousand CAD | 34.83% |
| 2015 Q3 | -67.88 Thousand CAD | -2917.81% |
| 2015 Q4 | -41.37 Thousand CAD | 39.05% |
| 2015 Q2 | 2409.00 CAD | 101.48% |
| 2015 FY | - CAD | 44.33% |
| 2014 Q1 | -41.75 Thousand CAD | 60.0% |
| 2014 Q2 | -91.14 Thousand CAD | -118.31% |
| 2014 Q3 | -112.26 Thousand CAD | -23.17% |
| 2014 Q4 | -250.41 Thousand CAD | -123.07% |
| 2014 FY | - CAD | -241.25% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | -104.37 Thousand CAD | -100.67% |
| 2013 Q3 | -52.01 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|